The Korean journal of internal medicine

  • 제31권4호
  • /
  • Pages.730-738
  • /
  • 2016
  • /
  • 1226-3303(pISSN)
  • /
  • 2005-6648(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

Liver cirrhosis leads to poorer survival in patients with end-stage renal disease

  • Kim, Ae Jin (Department of Internal Medicine, Gachon University Gil Medical Center, Graduate School of Medicine, Gachon University) ;
  • Lim, Hye Jin (Department of Internal Medicine, Gachon University Gil Medical Center, Graduate School of Medicine, Gachon University) ;
  • Ro, Han (Department of Internal Medicine, Gachon University Gil Medical Center, Graduate School of Medicine, Gachon University) ;
  • Jung, Ji Yong (Department of Internal Medicine, Gachon University Gil Medical Center, Graduate School of Medicine, Gachon University) ;
  • Lee, Hyun Hee (Department of Internal Medicine, Gachon University Gil Medical Center, Graduate School of Medicine, Gachon University) ;
  • Chung, Wookyung (Department of Internal Medicine, Gachon University Gil Medical Center, Graduate School of Medicine, Gachon University) ;
  • Chang, Jae Hyun (Department of Internal Medicine, Gachon University Gil Medical Center, Graduate School of Medicine, Gachon University)
  • 투고 : 2014.10.28
  • 심사 : 2015.03.06
  • 발행 : 2016.07.01
⟨ 이전 논문 다음 논문 ⟩

초록

Background/Aims: Liver cirrhosis (LC) is an important problem in patients with end-stage renal disease (ESRD). Few studies have investigated the influence of LC on mortality in patients with ESRD. This study investigated the association between LC and mortality among patients with ESRD and compare mortality between two dialysis modalities. Methods: Adult patients (${\geq}18$ years of age) starting dialysis for ESRD were enrolled in the present study from 2000 to 2011. We analyzed 1,069 patients with ESRD; of these, 742 patients were undergoing hemodialysis (HD) and 327 patients were undergoing peritoneal dialysis (PD). Results: The prevalence of LC was 44 of 1,069 patients (4.1%). The cumulative 1-, 3-, and 5-year survival rates of noncirrhotic patients were 93%, 83%, and 73%, respectively, whereas the equivalent survival rates of cirrhotic patients were 90%, 68%, and 48%, respectively (p = 0.011). After adjustment, LC was an independent risk factor for death in patients with ESRD. No difference in mortality associated with LC was found between the HD and PD subgroups. Conclusions: Of the patients with ESRD, cirrhotic patients had poorer survival than noncirrhotic patients. Among patients with ESRD and LC, survival of patients undergoing PD may be comparable with that of patients undergoing HD.

키워드

참고문헌

  1. Collins AJ, Foley RN, Chavers B, et al. United States Renal Data System 2011 Annual Data Report: atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis 2012;59(1 Suppl 1):A7, e1-e420.
  2. Jin DC. Current status of dialysis therapy in Korea. Korean J Intern Med 2011;26:123-131. https://doi.org/10.3904/kjim.2011.26.2.123
  3. Patel PR, Thompson ND, Kallen AJ, Arduino MJ. Epidemiology, surveillance, and prevention of hepatitis C virus infections in hemodialysis patients. Am J Kidney Dis 2010;56:371-378. https://doi.org/10.1053/j.ajkd.2010.01.025
  4. Edey M, Barraclough K, Johnson DW. Review article: hepatitis B and dialysis. Nephrology (Carlton) 2010;15:137-145. https://doi.org/10.1111/j.1440-1797.2009.01268.x
  5. Han YS, Kim BH, Baek IY, et al. The change of the etiology, complications and cause of death of the liver cirrhosis in 1990s. Korean J Hepatol 2000;6:328-339.
  6. Chien CC, Wang JJ, Sun YM, et al. Long-term survival and predictors for mortality among dialysis patients in an endemic area for chronic liver disease: a national cohort study in Taiwan. BMC Nephrol 2012;13:43. https://doi.org/10.1186/1471-2369-13-43
  7. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095-2128. https://doi.org/10.1016/S0140-6736(12)61728-0
  8. Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol 2013;58:593-608. https://doi.org/10.1016/j.jhep.2012.12.005
  9. Fede G, D'Amico G, Arvaniti V, et al. Renal failure and cirrhosis: a systematic review of mortality and prognosis. J Hepatol 2012;56:810-818. https://doi.org/10.1016/j.jhep.2011.10.016
  10. Huang ST, Chuang YW, Cheng CH, et al. Outcome of peritoneal dialysis in cirrhotic patients with end-stage renal disease: a 24-years' experience in Taiwan. Clin Nephrol 2011;76:306-313. https://doi.org/10.5414/CN107070
  11. Chaudhary K, Khanna R. Renal replacement therapy in end-stage renal disease patients with chronic liver disease and ascites: role of peritoneal dialysis. Perit Dial Int 2008;28:113-117.
  12. Chaudhary K. What is the best chronic dialysis modality for ESRD patients with end-stage liver disease? Semin Dial 2011;24:414-415. https://doi.org/10.1111/j.1525-139X.2011.00907.x
  13. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-649. https://doi.org/10.1002/bjs.1800600817
  14. Hwang SJ, Yang WC, Lin MY, Mau LW, Chen HC; Taiwan Society of Nephrology. Impact of the clinical conditions at dialysis initiation on mortality in incident haemodialysis patients: a national cohort study in Taiwan. Nephrol Dial Transplant 2010;25:2616-2624. https://doi.org/10.1093/ndt/gfq308
  15. Johnson DW, Dent H, Yao Q, et al. Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data. Nephrol Dial Transplant 2009;24:1598-1603. https://doi.org/10.1093/ndt/gfn684
  16. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006;44:217-231. https://doi.org/10.1016/j.jhep.2005.10.013
  17. De Vecchi AF, Colucci P, Salerno F, Scalamogna A, Ponticelli C. Outcome of peritoneal dialysis in cirrhotic patients with chronic renal failure. Am J Kidney Dis 2002;40:161-168. https://doi.org/10.1053/ajkd.2002.33925
  18. Hsiang JC, Gane EJ, Bai WW, Gerred SJ. Type 2 diabetes: a risk factor for liver mortality and complications in hepatitis B cirrhosis patients. J Gastroenterol Hepatol 2015;30:591-599. https://doi.org/10.1111/jgh.12790
  19. Elkrief L, Chouinard P, Bendersky N, et al. Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C. Hepatology 2014;60:823-831. https://doi.org/10.1002/hep.27228
  20. Kim MS, Yang JW, Han ST, et al. Comparison between hemodialysis and peritoneal dialysis in patients with endstage renal disease and liver cirrhosis. Korean J Nephrol 2007;26:705-715.
  21. Marcus RG, Messana J, Swartz R. Peritoneal dialysis in end-stage renal disease patients with preexisting chronic liver disease and ascites. Am J Med 1992;93:35-40. https://doi.org/10.1016/0002-9343(92)90677-4
  22. Such J, Runyon BA. Spontaneous bacterial peritonitis. Clin Infect Dis 1998;27:669-674. https://doi.org/10.1086/514940
  23. Martin PY, Gines P, Schrier RW. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med 1998;339:533-541. https://doi.org/10.1056/NEJM199808203390807
  24. Winney RJ, Kean DM, Best JJ, Smith MA. Changes in brain water with haemodialysis. Lancet 1986;2:1107-1108.
  25. Donovan JP, Schafer DF, Shaw BW Jr, Sorrell MF. Cerebral oedema and increased intracranial pressure in chronic liver disease. Lancet 1998;351:719-721. https://doi.org/10.1016/S0140-6736(97)07373-X

피인용 문헌

  1. Effect of Liver Cirrhosis on the Outcomes of Peritoneal Dialysis vol.39, pp.6, 2019, https://doi.org/10.3747/pdi.2018.00247
  2. Effect of Liver Cirrhosis on the Outcomes of Peritoneal Dialysis vol.39, pp.6, 2019, https://doi.org/10.3747/pdi.2018.00247
  3. Chronic renal dysfunction in cirrhosis: A new frontier in hepatology vol.27, pp.11, 2021, https://doi.org/10.3748/wjg.v27.i11.990
  4. Peritoneal Dialysis Use in Patients With Ascites: A Review vol.78, pp.5, 2016, https://doi.org/10.1053/j.ajkd.2021.04.010